[ad_1] GlaxoSmithKline (GSK) and Medicines for Malaria Venture (MMV) announced today that the Food and Drug Administration (FDA) has approved the single dose of Krintafel (tafenoquine) for radical treatment (relapse prevention ) …
Read More »Malaria drug approved for the radical treatment of P. Vivax Malaria – Precision Vaccinations
